Cost-effectiveness of enoxaparin versus aspirin in the prevention of venous thromboembolism after total hip or knee arthroplasty: an analysis from the CRISTAL cluster-randomized trial.,The Bone & Joint Journal

当前位置： X-MOL 学术 › Bone Joint J. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Cost-effectiveness of enoxaparin versus aspirin in the prevention of venous thromboembolism after total hip or knee arthroplasty: an analysis from the CRISTAL cluster-randomized trial.
The Bone & Joint Journal ( IF 4.9 ) Pub Date : 2024-06-01 , DOI: 10.1302/0301-620x.106b6.bjj-2023-0783.r2

The aim of this study was to evaluate the healthcare costs and benefits of enoxaparin compared to aspirin in the prevention of symptomatic venous thromboembolism (VTE) after total hip arthroplasty (THA) or total knee arthroplasty (TKA) using data from the CRISTAL trial.

中文翻译：

依诺肝素与阿司匹林预防全髋关节或膝关节置换术后静脉血栓栓塞的成本效益：CRISTAL 整群随机试验的分析。

本研究的目的是利用 CRISTAL 试验的数据，评估依诺肝素与阿司匹林相比，在预防全髋关节置换术 (THA) 或全膝关节置换术 (TKA) 后症状性静脉血栓栓塞 (VTE) 方面的医疗成本和益处。

更新日期：2024-06-01

点击分享查看原文

点击收藏

阅读更多本刊最新论文

全部期刊列表>>